These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 23845802)

  • 1. Rotavirus-associated hospitalization and emergency department costs and rotavirus vaccine program impact.
    Kilgore A; Donauer S; Edwards KM; Weinberg GA; Payne DC; Szilagyi PG; Rice M; Cassedy A; Ortega-Sanchez IR; Parashar UD; Staat MA
    Vaccine; 2013 Aug; 31(38):4164-71. PubMed ID: 23845802
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost-effectiveness of rotavirus vaccination in Turkey.
    Koksal T; Akelma AZ; Koksal AO; Kutukoglu I; Ozdemir O; Yuksel CN; Bozkaya D; Catal F; Sari S
    J Microbiol Immunol Infect; 2017 Oct; 50(5):693-699. PubMed ID: 27107612
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Budget impact and cost-effectiveness of including a pentavalent rotavirus vaccine in the New Zealand childhood immunization schedule.
    Milne RJ; Grimwood K
    Value Health; 2009 Sep; 12(6):888-98. PubMed ID: 19490550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decline in Emergency Department Visits for Acute Gastroenteritis Among Children in 10 US States After Implementation of Rotavirus Vaccination, 2003 to 2013.
    Shah MP; Tate JE; Steiner CA; Parashar UD
    Pediatr Infect Dis J; 2016 Jul; 35(7):782-6. PubMed ID: 27088585
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost-Effectiveness of Monovalent Rotavirus Vaccination of Infants in Malawi: A Postintroduction Analysis Using Individual Patient-Level Costing Data.
    Bar-Zeev N; Tate JE; Pecenka C; Chikafa J; Mvula H; Wachepa R; Mwansambo C; Mhango T; Chirwa G; Crampin AC; Parashar UD; Costello A; Heyderman RS; French N; Atherly D; Cunliffe NA;
    Clin Infect Dis; 2016 May; 62 Suppl 2(Suppl 2):S220-8. PubMed ID: 27059360
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Population-Level Impact of Ontario's Infant Rotavirus Immunization Program: Evidence of Direct and Indirect Effects.
    Wilson SE; Rosella LC; Wang J; Le Saux N; Crowcroft NS; Harris T; Bolotin S; Deeks SL
    PLoS One; 2016; 11(5):e0154340. PubMed ID: 27168335
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of the national rotavirus vaccination programme on acute gastroenteritis in England and associated costs averted.
    Thomas SL; Walker JL; Fenty J; Atkins KE; Elliot AJ; Hughes HE; Stowe J; Ladhani S; Andrews NJ
    Vaccine; 2017 Jan; 35(4):680-686. PubMed ID: 28007397
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-effectiveness analysis of a rotavirus immunization program for the United States.
    Tucker AW; Haddix AC; Bresee JS; Holman RC; Parashar UD; Glass RI
    JAMA; 1998 May; 279(17):1371-6. PubMed ID: 9582045
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Burden of acute gastroenteritis hospitalizations and emergency department visits in US children that is potentially preventable by rotavirus vaccination: a probe study using the now-withdrawn rotashield vaccine.
    Tate JE; Curns AT; Cortese MM; Weintraub ES; Hambidge S; Zangwill KM; Patel MM; Baggs JM; Parashar UD
    Pediatrics; 2009 Mar; 123(3):744-9. PubMed ID: 19254997
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Using emergency department syndromic surveillance to investigate the impact of a national vaccination program: A retrospective observational study.
    Hughes HE; Elliot AJ; Hughes TC; Hungerford D; Morbey RA; Smith GE; Vivancos R; O'Brien SJ
    PLoS One; 2020; 15(10):e0240021. PubMed ID: 33031389
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Economic analysis for evidence-based policy-making on a national immunization program: a case of rotavirus vaccine in Thailand.
    Muangchana C; Riewpaiboon A; Jiamsiri S; Thamapornpilas P; Warinsatian P
    Vaccine; 2012 Apr; 30(18):2839-47. PubMed ID: 22387220
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term impact of self-financed rotavirus vaccines on rotavirus-associated hospitalizations and costs in the Valencia Region, Spain.
    Orrico-Sanchez A; López-Lacort M; Pérez-Vilar S; Díez-Domingo J
    BMC Infect Dis; 2017 Apr; 17(1):267. PubMed ID: 28399824
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-effectiveness of introducing a rotavirus vaccine in developing countries: the case of Mexico.
    Valencia-Mendoza A; Bertozzi SM; Gutierrez JP; Itzler R
    BMC Infect Dis; 2008 Jul; 8():103. PubMed ID: 18664280
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Projected cost-effectiveness of rotavirus vaccination for children in Asia.
    Podewils LJ; Antil L; Hummelman E; Bresee J; Parashar UD; Rheingans R
    J Infect Dis; 2005 Sep; 192 Suppl 1():S133-45. PubMed ID: 16088797
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Universal rotavirus vaccination program in Sicily: Reduction in health burden and cost despite low vaccination coverage.
    Costantino C; Restivo V; Tramuto F; Casuccio A; Vitale F
    Hum Vaccin Immunother; 2018; 14(9):2297-2302. PubMed ID: 29757707
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The hidden costs and characteristics of childhood rotavirus emergency visits in Canada.
    Le Saux N; Bettinger J; Déry P; Embree J; Vaudry W; Halperin SA; McDermid A; Booth TF; Coyle D
    Pediatr Infect Dis J; 2012 Feb; 31(2):159-63. PubMed ID: 22001965
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-effectiveness of childhood rotavirus vaccination in Taiwan.
    Wu CL; Yang YC; Huang LM; Chen KT
    Vaccine; 2009 Mar; 27(10):1492-9. PubMed ID: 19186200
    [TBL] [Abstract][Full Text] [Related]  

  • 18. All-cause gastroenteritis and rotavirus-coded hospitalizations among US children, 2000-2009.
    Desai R; Curns AT; Steiner CA; Tate JE; Patel MM; Parashar UD
    Clin Infect Dis; 2012 Aug; 55(4):e28-34. PubMed ID: 22543022
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effectiveness of the pentavalent rotavirus vaccine in preventing gastroenteritis in the United States.
    Wang FT; Mast TC; Glass RJ; Loughlin J; Seeger JD
    Pediatrics; 2010 Feb; 125(2):e208-13. PubMed ID: 20100757
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anticipating rotavirus vaccines--a pre-vaccine assessment of incidence and economic burden of rotavirus hospitalizations among children < 5 year of age in Libya, 2012-13.
    Alkoshi S; Leshem E; Parashar UD; Dahlui M
    BMC Public Health; 2015 Jan; 15():26. PubMed ID: 25616973
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.